The need for speed: an update on methamphetamine addiction
- PMID: 16951733
- PMCID: PMC1557685
The need for speed: an update on methamphetamine addiction
Abstract
The psychostimulant methamphetamine (MA) is a highly addictive drug that has surged in popularity over the last decade in North America. A burgeoning number of clandestine drug laboratories has led to dramatic increases in MA production, which have resulted in significant public health, legal and environmental problems. Current evidence indicates that exposure to MA is neurotoxic, and neuroimaging studies confirm that long-term use in humans may lead to extensive neural damage. These physiological changes are commonly associated with persistent forms of cognitive impairment, including deficits in attention, memory and executive function. In the present review, we provide a comprehensive description of the factors relating to MA use and the major health-related consequences, with an emphasis on MA-induced psychosis. It is hoped that increased knowledge of MA abuse will provide the basis for future treatment strategies.
La méthamphétamine (MA), un psychostimulant, est une drogue très toxicomanogène dont la popularité a grimpé en flèche au cours de la dernière décennie en Amérique du Nord. Des laboratoires clandestins de plus en plus nombreux ont entraîné des augmentations spectaculaires de la production de MA et, par conséquent, d'importants problèmes pour la santé publique, la loi et l'environnement. Les données actuelles indiquent que l'exposition à la MA est neurotoxique et des études de neuro-imagerie confirment que l'utilisation chronique chez l'être humain peut causer des dommages nerveux étendus. On établit couramment un lien entre ces changements physiologiques et des formes persistantes de déficience cognitive, y compris des déficits de l'attention, de la mémoire et de l'exécution. Nous présentons dans cette analyse critique une description détaillée des facteurs reliés à l'utilisation de la MA et ses principales répercussions sur la santé, en insistant sur la psychose causée par la MA. On espère qu'une meilleure connaissance de l'abus de MA servira de base à de futures stratégies de traitement.
Figures
Similar articles
-
[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].Psychiatr Prax. 2005 Jan;32(1):13-7. doi: 10.1055/s-2003-814996. Psychiatr Prax. 2005. PMID: 15633070 German.
-
Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies.Biomed Pharmacother. 2022 Oct;154:113591. doi: 10.1016/j.biopha.2022.113591. Epub 2022 Aug 22. Biomed Pharmacother. 2022. PMID: 36007276 Review.
-
An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.Cogn Behav Neurol. 2008 Jun;21(2):98-103. doi: 10.1097/WNN.0b013e31816bdf90. Cogn Behav Neurol. 2008. PMID: 18541986
-
Psychotic symptoms in methamphetamine psychotic in-patients.Int J Neuropsychopharmacol. 2003 Dec;6(4):347-52. doi: 10.1017/S1461145703003675. Int J Neuropsychopharmacol. 2003. PMID: 14604449
-
Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.Drug Alcohol Depend. 2013 May 1;129(3):167-79. doi: 10.1016/j.drugalcdep.2012.11.016. Epub 2012 Dec 27. Drug Alcohol Depend. 2013. PMID: 23273775 Review.
Cited by
-
Patterns and Characteristics of Amphetamine-type Stimulant Use in a North-eastern State of India: A Cross-sectional Study.Indian J Psychol Med. 2024 Apr 4:02537176241236899. doi: 10.1177/02537176241236899. Online ahead of print. Indian J Psychol Med. 2024. PMID: 39564291 Free PMC article.
-
Identifying methamphetamine use predictors in HIV infection: Immune-dopaminergic signatures in peripheral leukocytes and the role of COMT genotype.Brain Behav Immun Health. 2024 Oct 5;42:100873. doi: 10.1016/j.bbih.2024.100873. eCollection 2024 Dec. Brain Behav Immun Health. 2024. PMID: 39430881 Free PMC article.
-
SIPD or psychotic disorder with stimulant use.Schizophr Res Cogn. 2024 Oct 5;39:100332. doi: 10.1016/j.scog.2024.100332. eCollection 2025 Mar. Schizophr Res Cogn. 2024. PMID: 39430164 Free PMC article. No abstract available.
-
Drug-induced change in transmitter identity is a shared mechanism generating cognitive deficits.Nat Commun. 2024 Sep 26;15(1):8260. doi: 10.1038/s41467-024-52451-x. Nat Commun. 2024. PMID: 39327428 Free PMC article.
-
Computational Mechanisms Underlying Multi-Step Planning Deficits in Methamphetamine Use Disorder.medRxiv [Preprint]. 2024 Jun 28:2024.06.27.24309581. doi: 10.1101/2024.06.27.24309581. medRxiv. 2024. PMID: 38978681 Free PMC article. Preprint.
References
-
- Sulzer D, Sonders MS, Poulsen NW, et al. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005;75:406-33. - PubMed
-
- Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003;15:317-25. - PubMed
-
- Izenwasser S. The role of the dopamine transporter in cocaine abuse. Neurotox Res 2004;6:379-83. - PubMed
-
- Brown JM, Hanson GR, Fleckenstein AE. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 2001;296:762-7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
